Literature DB >> 19148577

Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays.

P Rohner1, V Jacomo, R Studer, J Schrenzel, J-D Graf.   

Abstract

BACKGROUND: Pneumocystis jirovecii is an opportunistic pathogen that causes pneumonia, particularly in immunodeficient hosts.
MATERIALS AND METHODS: We retrospectively compared the results obtained by two staining methods (toluidine blue and calcofluor white) and two quantitative (q) real time PCR assays for the detection of P. jirovecii in bronchoalveolar lavage (BAL) specimens. For the qPCR assays, we used newly selected probes and primers targeting the Kex-1 gene, which codes for a serine endoprotease, and compared the results to those from the published assay targeting the beta-tubulin gene.
RESULTS: A total of 1,843 BAL specimens were analyzed microscopically in parallel, and 74 (4.0%) were found to be positive with both stains, 23 (1.2%) were positive only with the toluidine blue stain, and six (0.3%) only with the calcofluor stain (p = 0.003). Of these, a selection of 186 consecutive BAL fluid samples were tested by qPCR using the respective different primer pairs. 21 of the 186 samples (11.3%) were microscopically positive with both stains as well as qPCR positive after 18-31 cycles (corresponding to 5.24 x 10(6) copies/ml to 640 copies/ml of native BAL) using the Kex-1 primer pair and between 21-33 cycles using the beta-tubulin assay. A good correlation between semi-quantitative microscopy and the number of PCR cycles needed for a positive signal was noted. Of the remaining 165 samples, 153 (82%) were both microscopically and PCR negative (PCR with the two sets of primers); the remaining 12 samples (7%) were Kex-1-based PCR positive (from cycles 33 to 41, corresponding to 160 copies/ml of BAL or less) but microscopically negative. Of these latter samples, ten (6%) were also positive (from cycles 34 to 38) with the primers targeting the beta-tubulin gene. Taking microscopy as a reference, the sensitivity of qPCR targeting the Kex-1 gene was 100%, and the specificity was 92.4%.
CONCLUSION: The sensitive qPCR analysis proved to be a rapid and reliable method to detect P. jirovecii in BAL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19148577     DOI: 10.1007/s15010-008-8027-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  21 in total

1.  Quantitative TaqMan PCR for detection of Pneumocystis jiroveci.

Authors:  Françoise Brancart; Hector Rodriguez-Villalobos; Pierre-Alain Fonteyne; Daliana Peres-Bota; Corinne Liesnard
Journal:  J Microbiol Methods       Date:  2005-06       Impact factor: 2.363

2.  Molecular probes for the detection of Pneumocystis carinii.

Authors:  A E Wakefield; S Banerji; F J Pixley; J M Hopkin
Journal:  Trans R Soc Trop Med Hyg       Date:  1990       Impact factor: 2.184

3.  Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain.

Authors:  N Respaldiza; M A Montes-Cano; F J Dapena; C de la Horra; I Mateos; F J Medrano; E Calderon; J M Varela
Journal:  Clin Microbiol Infect       Date:  2005-12       Impact factor: 8.067

4.  A comparison of modified methenamine silver and toluidine blue stains for the detection of Pneumocystis carinii in bronchoalveolar lavage specimens from immunosuppressed patients.

Authors:  I L Paradis; C Ross; A Dekker; J Dauber
Journal:  Acta Cytol       Date:  1990 Jul-Aug       Impact factor: 2.319

5.  A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid.

Authors:  Rodney C Arcenas; James R Uhl; Seanne P Buckwalter; Andrew H Limper; Dana Crino; Glenn D Roberts; Nancy L Wengenack
Journal:  Diagn Microbiol Infect Dis       Date:  2006-01-19       Impact factor: 2.803

6.  Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR.

Authors:  A Sing; A M Geiger; M Hogardt; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii.

Authors:  Hans Henrik Larsen; Joseph A Kovacs; Frida Stock; Vibeke H Vestereng; Bettina Lundgren; Steven H Fischer; Vee J Gill
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens.

Authors:  Pierre Flori; Bahrie Bellete; Fabrice Durand; Hélène Raberin; Céline Cazorla; Jamal Hafid; Frédéric Lucht; Roger Tran Manh Sung
Journal:  J Med Microbiol       Date:  2004-07       Impact factor: 2.472

9.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.

Authors:  J F Huggett; M S Taylor; G Kocjan; H E Evans; S Morris-Jones; V Gant; T Novak; A M Costello; A Zumla; R F Miller
Journal:  Thorax       Date:  2007-08-10       Impact factor: 9.139

10.  Pneumocystis jirovecii in general population.

Authors:  Francisco J Medrano; Marco Montes-Cano; Manuel Conde; Carmen de la Horra; Nieves Respaldiza; Antonia Gasch; Maria J Perez-Lozano; Jose M Varela; Enrique J Calderon
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more
  14 in total

1.  Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.

Authors:  Françoise Botterel; Odile Cabaret; Françoise Foulet; Catherine Cordonnier; Jean-Marc Costa; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform.

Authors:  Alexander H Dalpke; Marjeta Hofko; Stefan Zimmermann
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

Review 3.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

4.  Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Authors:  Philippe M Hauser; Jacques Bille; Cornelia Lass-Flörl; Christian Geltner; Marta Feldmesser; Michael Levi; Hitesh Patel; Victoria Muggia; Barbara Alexander; Martin Hughes; Sarah A Follett; Xiaohui Cui; Flora Leung; Gillian Morgan; Adrian Moody; David S Perlin; David W Denning
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

5.  Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.

Authors:  Valerio Del Bono; Alessandra Mularoni; Elisa Furfaro; Emanuele Delfino; Lorenzo Rosasco; Franca Miletich; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

6.  Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).

Authors:  Julie R Harris; Barbara J Marston; Nalinee Sangrujee; Desiree DuPlessis; Benjamin Park
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

Review 7.  Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review.

Authors:  Li-Chao Fan; Hai-Wen Lu; Ke-Bin Cheng; Hui-Ping Li; Jin-Fu Xu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

8.  Application of real time polymerase chain reaction targeting kex 1 gene & its comparison with the conventional methods for rapid detection of Pneumocystis jirovecii in clinical specimens.

Authors:  Mani Revathy; Kulandai Lily Therese; Radhakishnan Bagyalakshmi; Chokaliingam Chandrasekar; Suria Kumar; Hajib N Madhavan
Journal:  Indian J Med Res       Date:  2014-09       Impact factor: 2.375

9.  Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool.

Authors:  Cecilie Juul Hviid; Marianne Lund; Allan Sørensen; Svend Ellermann-Eriksen; Bente Jespersen; Mette Yde Dam; Jens Frederik Dahlerup; Thomas Benfield; Sanne Jespersen; Lars Jørgen Østergaard; Alex Lund Laursen
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

Review 10.  Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.

Authors:  Xavier Iriart; Marine Le Bouar; Nassim Kamar; Antoine Berry
Journal:  J Fungi (Basel)       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.